Multiple abstracts accepted featuring imdusiran clinical data – highlighting progress toward a potential functional cure for chronic hepatitis B ...
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical stage biotechnology company dedicated to creating novel, small ...
Bluejay Therapeutics Announces Data Presentations in Chronic Hepatitis D (CHD) and Chronic Hepatitis B (CHB) at Upcoming American Association for the Study of Liver Diseases (AASLD) The Liver ...
Preclinical data for VCN-12, the next candidate from Theriva’s VCN-X discovery program, highlight a novel mechanism of action ...
The idea that a single-celled bacterium can defend itself against viruses in a similar way as the 1.8-trillion-cell human ...
Viruses are so simple in their structure, they may not even qualify as living things. Yet, they are ruthless in their robotic ...
Virion Therapeutics, LLC, a clinical stage biotechnology company, developing novel T cell-based immunotherapies that utilize ...
The work, described in a preprint paper, has the potential to create new treatments and accelerate research into artificially ...
The 2024-2025 COVID-19 vaccine targets the Omicron JN.1 lineage. Low vaccination rates are indicative of COVID-19, but a majority of patients are getting their COVID-19 vaccine at a pharmacy. The ...
Growing numbers of West Nile virus infection cases, fueled by climate change, are sparking fears among citizens and health care providers in Europe. A Clinical Insight in the European Journal of ...
Kaiser Permanente Pediatrician Lisa Ann Denike is informing parents that their kids could be more susceptible to viruses like influenza, cold, COVID-19 and Respiratory Syncytial Virus throughout the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback